Varex Imaging Corporation (VREX)

Over the past six months, Varex Imaging Corp.'s stock price has increased by 59.49%, with an 18.17% rise in the past month as of February 5, 2026. In Q4 2025, Varex reported EPS of $0.37 and revenue of $228.90 million, exceeding expectations due to strong global CT tube sales and cargo systems business. Varex received orders for cargo inspection systems valued at approximately $25 million USD. Between January 21, 2025, and January 20, 2026, the share price experienced a decline of 2.59%. A sell signal was issued from a pivot top point on January 22, 2026, and the stock has since fallen by 2.51%, with an additional sell signal from the 3-month MACD.

Demand for Varex Imaging Corp.'s products exhibits some predictable elements, particularly within its Medical segment, due to the regular replacement of X-ray tubes. Customer destocking in certain regions was expected to continue into the first half of fiscal year 2025, indicating some cyclicality, but the need for replacement components provides a baseline of demand.

Varex Imaging Corp. designs and manufactures X-ray imaging components and image processing solutions for the Health Technology sector and Medical Specialties industry, operating through Medical and Industrial segments. The Medical segment provides components for medical imaging procedures, while the Industrial segment focuses on X-ray imaging products for security and nondestructive testing. Varex supplies components for new systems and the replacement market.

Varex Imaging Corp. has a global presence with manufacturing facilities in the United States, the Netherlands, Germany, Finland, and the Philippines, covering the Americas, Europe, the Middle East, Africa, and Asia Pacific. By the end of fiscal year 2025, Varex planned a new operational launch in India.

Varex Imaging Corp. maintains a strong brand reputation as the world's largest independent supplier and manufacturer of X-ray imaging components and image processing solutions, with a 75+ year history of innovation. No specific negative events have widely impacted its brand reputation in the past year, but the company faces competition, customer concentration, regulatory challenges, and macroeconomic headwinds.

Varex Imaging Corp.'s ownership is heavily weighted towards institutional investors, who held approximately 96.70% of the total shares as of 2025Q4. Major institutional owners include Pzena Investment Management Llc, BlackRock, Inc., and Vanguard Group Inc. Individual investors and other non-institutional entities hold a smaller portion of the float (2.83%), while insiders hold a small percentage of shares, typically under 3% (1.66% as of one report).